158 related articles for article (PubMed ID: 18003659)
21. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
22. Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation.
Hu B; Wu Z; Liu T; Ullenbruch MR; Jin H; Phan SH
Am J Respir Cell Mol Biol; 2007 Jan; 36(1):78-84. PubMed ID: 16858008
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein.
Shen X; Hu PP; Liberati NT; Datto MB; Frederick JP; Wang XF
Mol Biol Cell; 1998 Dec; 9(12):3309-19. PubMed ID: 9843571
[TBL] [Abstract][Full Text] [Related]
24. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins.
Hua X; Miller ZA; Wu G; Shi Y; Lodish HF
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13130-5. PubMed ID: 10557285
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
Choy L; Derynck R
J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
[TBL] [Abstract][Full Text] [Related]
26. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
27. The mechanism of nuclear export of Smad3 involves exportin 4 and Ran.
Kurisaki A; Kurisaki K; Kowanetz M; Sugino H; Yoneda Y; Heldin CH; Moustakas A
Mol Cell Biol; 2006 Feb; 26(4):1318-32. PubMed ID: 16449645
[TBL] [Abstract][Full Text] [Related]
28. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
29. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T
Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371
[TBL] [Abstract][Full Text] [Related]
30. Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity.
Kojic S; Nestorovic A; Rakicevic L; Protic O; Jasnic-Savovic J; Faulkner G; Radojkovic D
Arch Biochem Biophys; 2015 Mar; 569():45-53. PubMed ID: 25677450
[TBL] [Abstract][Full Text] [Related]
31. Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor-beta signaling by repressing SMAD3 transactivation.
Suh JH; Huang J; Park YY; Seong HA; Kim D; Shong M; Ha H; Lee IK; Lee K; Wang L; Choi HS
J Biol Chem; 2006 Dec; 281(51):39169-78. PubMed ID: 17074765
[TBL] [Abstract][Full Text] [Related]
32. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
33. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
34. Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action.
Li G; Wang S; Gelehrter TD
J Biol Chem; 2003 Oct; 278(43):41779-88. PubMed ID: 12902338
[TBL] [Abstract][Full Text] [Related]
35. Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription.
Leong GM; Subramaniam N; Figueroa J; Flanagan JL; Hayman MJ; Eisman JA; Kouzmenko AP
J Biol Chem; 2001 May; 276(21):18243-8. PubMed ID: 11278756
[TBL] [Abstract][Full Text] [Related]
36. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
37. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
Watanabe H; Francis JM; Woo MS; Etemad B; Lin W; Fries DF; Peng S; Snyder EL; Tata PR; Izzo F; Schinzel AC; Cho J; Hammerman PS; Verhaak RG; Hahn WC; Rajagopal J; Jacks T; Meyerson M
Genes Dev; 2013 Jan; 27(2):197-210. PubMed ID: 23322301
[TBL] [Abstract][Full Text] [Related]
38. The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis.
Bohinski RJ; Di Lauro R; Whitsett JA
Mol Cell Biol; 1994 Sep; 14(9):5671-81. PubMed ID: 8065304
[TBL] [Abstract][Full Text] [Related]
39. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif.
Makkar P; Metpally RP; Sangadala S; Reddy BV
J Mol Graph Model; 2009 Apr; 27(7):803-12. PubMed ID: 19157940
[TBL] [Abstract][Full Text] [Related]
40. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
Imoto S; Sugiyama K; Sekine Y; Matsuda T
FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
